Jeff Yass’s bioAffinity Technologies BIAFW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$6.84K Buy
21,366
+10,186
+91% +$2.1K ﹤0.01% 13264
2026
Q2
$1.55K Buy
11,180
+167
+2% +$43 ﹤0.01% 13234
2026
Q1
$3.63K Buy
+11,013
New +$3.49K ﹤0.01% 12999
2023
Q4
– Sell
-10,525
Closed -$961 – 12351
2023
Q3
$961 Buy
+10,525
New +$3.14K ﹤0.01% 11878
2023
Q2
– Sell
-14,077
Closed -$4.22K – 12072
2023
Q1
$4.22K Sell
14,077
-13,071
-48% -$4.88K ﹤0.01% 12323
2022
Q4
$11.4K Buy
27,148
+963
+4% +$424 ﹤0.01% 11914
2022
Q3
$9K Buy
+26,185
New +$27.1K ﹤0.01% 12792

Other funds holding BIAFW

Jeff Yass's BIAFW Position: Q3 2026 in Review

Jeff Yass increased its bioAffinity Technologies (BIAFW) stake by 91% in Q3 2026, buying an estimated $2.1K and bringing the position to 21,366 shares worth $6.84K. The position accounts for ﹤0.01% of the portfolio, ranked #13264.

Jeff Yass first reported a position in BIAFW in Q3 2022 and has held it in 7 quarters since. The position peaked at $11.4K in Q4 2022. 3 funds tracked by Wall St. Rank hold BIAFW as of Q3 2026.

  • Jeff Yass held 21,366 shares of bioAffinity Technologies worth $6.84K as of Q3 2026.
  • Jeff Yass bought 10,186 bioAffinity Technologies shares in Q3 2026, an estimated $2.1K.
  • bioAffinity Technologies made up ﹤0.01% of Jeff Yass's portfolio in Q3 2026, its #13264 holding.
  • Jeff Yass first reported a position in bioAffinity Technologies in Q3 2022 and has held it in 7 quarters since.
  • Jeff Yass's bioAffinity Technologies position peaked at $11.4K in Q4 2022.
  • 3 funds tracked by Wall St. Rank held bioAffinity Technologies as of Q3 2026.

Based on Susquehanna International Group's 13F filing for Q3 2026, filed 16 Nov 2026.